SCHEMBL21929622

SCHEMBL21929622

N#Cc1ccncc1-c1ccc(-c2ccccc2N2c3ccccc3N(c3ccccc3)c3ccccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.40
MGLL Q99685 1/20 0.38
ESR2 Q92731 1/20 0.38
ATR Q13535 1/20 0.38
SLC22A12 Q96S37 2/20 0.37
PRKAG1 P54619 2/20 0.36
PRKAA1 Q13131 2/20 0.36
PRKAB1 Q9Y478 2/20 0.36
MAPK1 P28482 1/20 0.36
PIP4K2A P48426 1/20 0.35
CYP11B2 P19099 1/20 0.35
GRIA1 P42261 1/20 0.35
GRIA3 P42263 1/20 0.35
PDE4D Q08499 1/20 0.35
ALDH1A1 P00352 2/20 0.35
CES2 O00748 1/20 0.35
BCHE P06276 1/20 0.35
GAA P10253 1/20 0.35
CES1 P23141 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21927730 0.93 ATR (0.38) PDE10AATRCYP11B2GRIA1GRIA3
SCHEMBL21929610 0.92 ATR (0.37) PDE10AATRSLC22A12GRIA1GRIA3
SCHEMBL21928178 0.91 CYP1A2 (0.39) PDE10AMGLLESR2SLC22A12MAPK1
SCHEMBL21927228 0.91 ATR (0.36) PDE10AATRSLC22A12GRIA1GRIA3
SCHEMBL21927697 0.86 ALDH1A1 (0.40) PDE10AMGLLATRCYP11B2ALDH1A1
SCHEMBL21927582 0.86 ATR (0.39) MGLLATRSLC22A12CYP11B2ALDH1A1
SCHEMBL21929612 0.84 UCHL1 (0.40) SLC22A12MAPK1GRIA1GRIA3PDE4D
SCHEMBL21928469 0.83 PDE10A (0.39) PDE10AMGLLESR2ATRSLC22A12
SCHEMBL21928514 0.83 PDE10A (0.39) PDE10AMGLLESR2ATRSLC22A12
SCHEMBL21927229 0.83 UCHL1 (0.39) SLC22A12MAPK1GRIA1GRIA3PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CCNT1, CCNA1, CCNE2 PDE10A 3198/4885MGLL 2767/4885ESR2 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.